Journals / Gülhane Tıp Dergisi / 2022 / Cilt: 64 - Sayı: 1

Clinical, surgical and histopathological characteristics of liver transplant recipients: An analysis of a large sample from Turkey

Pages
60–66
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The present study showed that demographic characteristics, etiological characteristics, postoperative complications, and mortality rates among LT recipients were consistent with the results of other centers around the world.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Liver transplantation (LT) is the most effective treatment method for end-stage liver failure and acute liver failure, depending on all causes.
📊
Key Findings & Data:Methods: In this single-center study, demographic, clinical, laboratory, radiological, surgical, and histopathological data of LT recipients aged 18 years or over between December 2017 and February 2021 were retrospectively analyzed.
💡
Conclusion & Impact:The present study showed that demographic characteristics, etiological characteristics, postoperative complications, and mortality rates among LT recipients were consistent with the results of other centers around the world.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Aims: Liver transplantation (LT) is the most effective treatment method for end-stage liver failure and acute liver failure, depending on all causes. This study aimed to examine the clinical, surgical, and histopathological characteristics of LT recipients in a referral center in Turkey. Methods: In this single-center study, demographic, clinical, laboratory, radiological, surgical, and histopathological data of LT recipients aged 18 years or over between December 2017 and February 2021 were retrospectively analyzed. All subjects were transplanted from live donors and cadavers. Results: The sample included 162 subjects [mean age: 50.1 (18-70) years; male: 64.8%. The proportion of live donor transplantation was 86.4% (n=140)]. The mean follow-up time was 20.5 months (1-39 months). The most common primary indication was hepatocellular carcinoma (n=43, 26.5%) and chronic hepatitis B virus infection-related cirrhosis (n=30, 18.5%). The most common postoperative complication was biliary complications (30.9%). One-year survival was 88.9%, two-year survival was 85.8%, and three-year survival was 83.3%. During the 3-year follow-up, the total graft loss rate was observed by 17.9%, and the mortality rate was 15.4%. Conclusions: The main goal in LT is the long-term survival of the graft and the patient. The present study showed that demographic characteristics, etiological characteristics, postoperative complications, and mortality rates among LT recipients were consistent with the results of other centers around the world.

🔖

Cite This Article

BULUR, A., SEVMİŞ, M. (2022). Clinical, surgical and histopathological characteristics of liver transplant recipients: An analysis of a large sample from Turkey. Gülhane Tıp Dergisi, Cilt: 64 - Sayı: 1, 60–66. https://ajindex.com/articles/526754

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Starzl TE, Marchioro TL, Porter KA, Brettschneider L. Homotransplantation of the liver. Transplantation. 1967;5:790- 803
  2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64:433-485
  3. Adam R, Karam V, Delvart V, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012;57:675-688
  4. Dutkowski P, De Rougemont O, Müllhaupt B, Clavien PA. Current and future trends in liver transplantation in Europe. Gastroenterology. 2010;138:802-9.e94
  5. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91-96
  6. Habib S, Berk B, Chang CC, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl. 2006;12:440- 447
  7. Benten D, Staufer K, Sterneck M. Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner. Nat Clin Pract Gastroenterol Hepatol. 2009;6:23- 36
  8. McGuire BM, Rosenthal P, Brown CC, et al. Long-term management of the liver transplant patient: recommendations for the primary care doctor. Am J Transplant. 2009;9:1988- 2003
  9. Varotti G, Grazi GL, Vetrone G, et al. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant. 2005;19:492-500
  10. Pfitzmann R, Nüssler NC, Hippler-Benscheidt M, Neuhaus R, Neuhaus P. Long-term results after liver transplantation.Transpl Int. 2008;21:234-246
  11. Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg. 2005;241:905-918
  12. Amador A, Charco R, Martí J, et al. One thousand liver transplants: the hospital clinic experience. Transplant Proc. 2005;37:3916-3918
  13. Strassburg CP, Manns MP. Lebertransplantation: Indikationen und Ergebnisse [Liver transplantation: indications and results]. Internist (Berl). 2009;50:550-560
  14. Busuttil RW, Lake JR. Role of tacrolimus in the evolution of liver transplantation. Transplantation. 2004;77(9 Suppl):S44-S51
  15. Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet. 2006;367:225-232
  16. Yaprak O, Dayangaç M, Demirbaş BT, Güler N, Yüzer Y, Tokat Y. Canlı vericiden sağ lob